Ovid Therapeutics Soars 12.73% on Penny Stock Hype

Ovid Therapeutics' stock surged by 12.73% in pre-market trading on July 18, 2025, marking a significant rise for the biopharmaceutical company.

Ovid Therapeutics has been in the spotlight recently due to its inclusion in various lists of top-performing penny stocks. The company's stock has been noted for its substantial gains, attracting the attention of investors looking for high-potential, low-cost investments.

Analysts have highlighted the potential upside for Ovid Therapeutics, citing its undervalued status in the healthcare sector. This positive outlook has contributed to the stock's recent surge, as investors anticipate future growth and profitability.